Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure–Activity Relationship Investigations
Authors:
- 11 December 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (24) , 17627-17655
Abstract
Toxoplasmosis, an infectious zoonotic disease caused by the apicomplexan parasite Toxoplasma gondii (T. gondii), is a major worldwide health problem. However, there are currently no effective options (chemotherapeutic drugs or prophylactic vaccines) for treating chronic latent toxoplasmosis infection. Accordingly, seeking more effective and safer chemotherapeutics for combating this disease remains a long-term and challenging objective. In this paper, we summarize possible molecular biotargets, with an emphasis on those that are druggable and promising, including, without limitation, calcium-dependent protein kinase 1, bifunctional thymidylate synthase-dihydrofolate reductase, and farnesyl diphosphate synthase. Meanwhile, as important components of medicinal chemistry, the binding modes and structure–activity relationship profiles of the corresponding inhibitors were also illuminated. We anticipate that this information will be helpful for further identification of more effective chemotherapeutic interventions to prevent and treat zoonotic infections caused by T. gondii.Keywords
Funding Information
- Kunming Medical University (2019FE001-031)
- Ministry of Science and Technology of the People's Republic of China (2021YFC2101000)
- National Natural Science Foundation of China (81971960)
- Natural Science Foundation of Shandong Province (ZR2021MH276)
- Key Laboratory of Forensic Toxicology, Ministry of Public Security (2021FTDWFX04)
This publication has 114 references indexed in Scilit:
- Synthetic Chondramide A Analogues Stabilize Filamentous Actin and Block Invasion by Toxoplasma gondiiJournal of Natural Products, 2013
- Multiple Determinants for Selective Inhibition of Apicomplexan Calcium-Dependent Protein Kinase CDPK1Journal of Medicinal Chemistry, 2012
- Development of Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitors with Potent Anti-Toxoplasma ActivityJournal of Medicinal Chemistry, 2012
- Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthaseBioorganic & Medicinal Chemistry, 2011
- Biostructural Features of Additional Jasplakinolide (Jaspamide) AnaloguesJournal of Natural Products, 2011
- Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl ReductaseJournal of Medicinal Chemistry, 2010
- Thiazole, Oxadiazole, and Carboxamide Derivatives of Artemisinin are Highly Selective and Potent Inhibitors of Toxoplasma gondiiJournal of Medicinal Chemistry, 2010
- CoMFA analysis of tgDHFR and rlDHFR based on antifolates with 6–5 fused ring system using the all-orientation search (AOS) routine and a modified cross-validated r2-guided region selection (q2-GRS) routine and its initial applicationBioorganic & Medicinal Chemistry, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Farnesyl Diphosphate Synthase: The Art of Compromise between Substrate Selectivity and StereoselectivityJournal of the American Chemical Society, 2006